Introduction
============

Severe sepsis is characterized by an aggressive inflammatory response, and is more common in patients with genetic polymorphisms that promote *greater* production of *pro*-inflammatory cytokines (e.g. -308A on the TNF gene). Thus, we hypothesized that the genetic predisposition to *lesser anti*-inflammatory response (-819T on the IL-10 gene) would also increase the risk of severe sepsis.

Methods
=======

As part of a first interim analysis of an ongoing NIH-sponsored multicenter study of Genetic and Inflammatory Markers of Sepsis (GenIMS), we analyzed 284 adult patients presenting to the Emergency Department (ED) with community-acquired pneumonia (CAP). We drew blood from patients presenting to EDs in southwest Pennsylvania with CAP for genotyping and plasma IL-10 levels. We defined severe sepsis as a Sequential Organ Failure Assessment Score increase of 2 for any one nonrespiratory organ, or an increase of 1 for any two nonrespiratory organs, or an absolute score of 3 or 4 for respiratory organs.

Results
=======

The cohort had a mean age of 66.9 ± 17.1 years; 49.6% were female; 87.7% were Caucasian; 30.3% had underlying respiratory disease; and 39.4% developed severe sepsis. Subjects with either genotype C/T or T/T at IL-10 -819 were associated with a greater risk of progression to severe sepsis compared with the common homozygote C/C (odds ratio = 1.71, *P* = 0.03). We did not find a consistent difference in plasma IL-10 levels in subjects with different genotypes.

Conclusion
==========

In this preliminary analysis of subjects with CAP, those with the IL-10 -819 C/T or T/T genotypes are more likely to develop severe sepsis compared with those with the usual homozygous C/C phenotype.

###### 

IL-10 -819 polymorphisms

                     All    C/C    C/T    T/T
  ------------------ ------ ------ ------ ------
  *n*                284    151    114    19
  \% severe sepsis   39.4   33.8   43.9   57.9
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